premargin

9587 Ratios - Lana Medical Co. | premargin

Income Statement Balance Sheet Cash Flow Ratios

Annual Semi-annual Quarterly

Ratios

	H1 2025Jun 30, 2025	H2 2024Dec 31, 2024	H1 2024Jun 30, 2024	H2 2023Dec 31, 2023	H1 2023Jun 30, 2023
Market & Price
Market Capitalization	193.86M	159.84M	113.94M	115.20M	—
Market Cap Growth	+70.1%	+38.8%	—	—	—
Enterprise Value	202.91M	161.28M	118.86M	120.12M	—
Last Close Price	3.59	2.96	2.11	2.13	—
Valuation Multiples
PE Ratio	17.28	12.83	-64.58	—	—
PS Ratio	1.98	1.90	1.88	2.37	—
PB Ratio	—	2.62	1.60	2.36	—
P/TBV Ratio	—	2.63	1.60	2.37	—
P/FCF Ratio	—	-42.89	—	-47.42	—
P/OCF Ratio	—	406.51	—	112.52	—
EV/Sales Ratio	2.07	1.92	1.96	2.47	—
EV/EBITDA Ratio	20.60	14.43	66.99	—	—
EV/EBIT Ratio	29.67	19.03	-15,928.59	—	—
EV/FCF Ratio	—	-43.28	—	-49.45	—
Leverage & Capital
Debt / Equity Ratio	—	0.25	0.14	0.23	—
Debt / FCF Ratio	—	-4.13	—	-4.66	—
Net Debt / Equity Ratio	—	0.15	0.02	-0.15	—
Net Debt / EBITDA Ratio	—	0.81	0.81	-6.67	—
Net Debt / FCF Ratio	—	-2.43	-0.35	3.06	—
Returns & Yields
Return on Capital Employed (ROCE)	—	+11.8%	0.0%	-0.6%	—
Earnings Yield	+5.8%	+7.8%	-1.5%	-1.7%	—
FCF Yield	-6.1%	-2.3%	-3.6%	-2.1%	—
Buyback Yield / Dilution	+1.0%	-16.8%	-20.0%	—	—